Discordance between mean glucose and time in range in relation to HbA1c in individuals with type 1 diabetes: results from the GOLD and SILVER trials
Sign Up to like & getrecommendations! Published in 2024 at "Diabetologia"
DOI: 10.1007/s00125-024-06151-2
Abstract: Previous studies have shown that individuals with similar mean glucose levels (MG) or percentage of time in range (TIR) may have different HbA1c values. The aim of this study was to further elucidate how MG… read more here.
Keywords: hba1c; time range; type diabetes; tir ... See more keywords
IDegLira improves time in range in a cohort of patients with type 2 diabetes: TiREX study
Sign Up to like & getrecommendations! Published in 2024 at "Acta Diabetologica"
DOI: 10.1007/s00592-024-02361-7
Abstract: To assess the effects of IDegLira on glucometric indices deriving from intermittently scanned Continuous Glucose Monitoring (isCGM) in patients with type 2 diabetes (T2D). Retrospective, observational, cohort, multi-center, “pre – post” study. All adults consecutively… read more here.
Keywords: ideglira; time range; patients type; type diabetes ... See more keywords
Two approximations of renewal function for any arbitrary lifetime distribution
Sign Up to like & getrecommendations! Published in 2019 at "Annals of Operations Research"
DOI: 10.1007/s10479-019-03356-2
Abstract: The renewal functions (RFs) of most distribution functions do not have closed-form expressions while such expressions are desired for the optimization problems involved RF. Many efforts have been made to develop approximations of RF. However,… read more here.
Keywords: arbitrary lifetime; two approximations; time range; lifetime distribution ... See more keywords
Efficacy of IDegLira Versus IDegAsp Therapy in Patients with Type 2 Diabetes: A Randomized Crossover Study by isCGM
Sign Up to like & getrecommendations! Published in 2022 at "Advances in Therapy"
DOI: 10.1007/s12325-022-02138-w
Abstract: We aimed to compare the efficacy of insulin degludec/insulin aspart (IDegAsp) and insulin degludec/liraglutide (IDegLira) in controlling glucose fluctuation and suppressing postprandial glucose levels using intermittently scanned continuous glucose monitoring. Twenty-four patients with type 2… read more here.
Keywords: idegasp; time range; study; ideglira ... See more keywords
Glycemic Variability and Time in Range During Self-titration of Once Daily Insulin Glargine 300 U/ml Versus Neutral Protamine Hagedorn Insulin in Insulin-naïve Chinese Type 2 Diabetes Patients
Sign Up to like & getrecommendations! Published in 2021 at "Diabetes Therapy"
DOI: 10.1007/s13300-021-01046-6
Abstract: To compare glycemic variability (GV) and time in range (TIR) in Chinese patients with type 2 diabetes (T2D) initiated on once-daily bedtime insulin glargine 300U/ml (Gla-300) versus neutral protamine Hagedorn (NPH) insulin using continuous glucose… read more here.
Keywords: insulin; gla 300; week; time range ... See more keywords
Continuous Glucose Monitoring and Time in Range: Association with Adverse Outcomes among People with Type 2 or Gestational Diabetes Mellitus
Sign Up to like & getrecommendations! Published in 2022 at "American Journal of Perinatology"
DOI: 10.1055/s-0043-1764208
Abstract: Abstract Objective Continuous glucose monitoring (CGM) has become available for women with type 2 diabetes mellitus (T2DM) or gestational diabetes mellitus (GDM) during pregnancy. The recommended time in range (TIR, blood glucose 70–140 mg/dL) and its… read more here.
Keywords: cgm; time; continuous glucose; time range ... See more keywords
Research progress in the application of time in range: more than a percentage.
Sign Up to like & getrecommendations! Published in 2023 at "Chinese medical journal"
DOI: 10.1097/cm9.0000000000002582
Abstract: ABSTRACT Glucose monitoring is an important part of medical care in diabetes mellitus, which not only helps assess glycemic control and treatment safety, but also assists with treatment adjustment. With the development of continuous glucose… read more here.
Keywords: tir; progress application; time range; range ... See more keywords
A Real-Time Range Indicator for EVs Using Web-Based Environmental Data and Sensorless Estimation of Regenerative Braking Power
Sign Up to like & getrecommendations! Published in 2018 at "IEEE Transactions on Vehicular Technology"
DOI: 10.1109/tvt.2018.2829728
Abstract: Most of the commercially available range indicator systems for electric vehicles (EVs) do not provide a sufficiently accurate range to destination, as the environmental factors and driver's behavior are generally not taken into account. In… read more here.
Keywords: real time; range; time; time range ... See more keywords
Time in range following flash glucose monitoring: Relationship with glycaemic control, diabetes‐related distress and resource utilisation in the Association of British Clinical Diabetologists national audit
Sign Up to like & getrecommendations! Published in 2022 at "Diabetic Medicine"
DOI: 10.1111/dme.14942
Abstract: The aim of this study was to understand the relationship between time in range (TIR) achieved using the isCGM with changes in glycaemic control, diabetes‐related distress (DRD) and resource utilisation in people living with diabetes. read more here.
Keywords: control diabetes; glycaemic control; time range; diabetes related ... See more keywords
‘We're taught green is good’: Perspectives on time in range and time in tight range from youth with type 1 diabetes, and parents of youth with type 1 diabetes
Sign Up to like & getrecommendations! Published in 2024 at "Diabetic Medicine"
DOI: 10.1111/dme.15423
Abstract: Continuous glucose monitoring (CGM) systems are standard of care for youth with type 1 diabetes with the goal of spending >70% time in range (TIR; 70–180 mg/dL, 3.9–10 mmol/L). We aimed to understand paediatric CGM user experiences… read more here.
Keywords: time; youth type; time range; youth ... See more keywords
Effect of insulin degludec versus insulin glargine U100 on time in range: SWITCH PRO, a crossover study of basal insulin‐treated adults with type 2 diabetes and risk factors for hypoglycaemia
Sign Up to like & getrecommendations! Published in 2021 at "Diabetes"
DOI: 10.1111/dom.14504
Abstract: To compare time in range (TIR) with use of insulin degludec U100 (degludec) versus insulin glargine U100 (glargine U100) in people with type 2 diabetes. read more here.
Keywords: insulin; time range; glargine u100; insulin degludec ... See more keywords